iTeos Therapeutics agrees to be acquired by Concentra Biosciences for $10.047 per share, plus contingent value rights. The acquisition offers iTeos stockholders a cash payment of $10.047 per share, ...
CARGO Therapeutics, Inc. has announced a definitive merger agreement with Concentra Biosciences, LLC, under which Concentra will acquire CARGO for $4.379 in cash per share of CARGO common stock, along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback